| Valiant Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|
| Debt-Equity Ratio | 0.36 | 0.71 | 0.39 | 0.01 |
| Long Term Debt-Equity Ratio | 0.36 | 0.70 | 0.37 | 0.00 |
| Current Ratio | 4.06 | 3.01 | 3.66 | 5.22 |
| Fixed Assets | 4.49 | 9.75 | 10.63 | 7.26 |
| Inventory | 15.79 | 23.16 | 26.66 | 30.04 |
| Debtors | 2.71 | 3.35 | 3.80 | 4.29 |
| Interest Cover Ratio | -48.38 | 153.56 | 596.86 | 27.42 |
| PBIDTM (%) | -1.05 | 11.96 | 15.18 | 28.19 |
| PBITM (%) | -2.13 | 11.50 | 14.33 | 26.76 |
| PBDTM (%) | -1.10 | 11.89 | 15.16 | 27.21 |
| CPM (%) | -0.50 | 9.15 | 10.29 | 18.20 |
| APATM (%) | -1.57 | 8.68 | 9.43 | 16.77 |
| ROCE (%) | -1.68 | 26.00 | 37.35 | 54.13 |
| RONW (%) | -1.70 | 33.73 | 34.37 | 34.53 |